Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Andrew M. Siroka"'
Autor:
Jerker Jonsson, Jad Shedrawy, Maria-Pia Hergens, Charlotte Deogan, Judith Bruchfeld, Andrew M. Siroka, Joanna Nederby Öhd, Knut Lönnroth
Publikováno v:
The European Journal of Health Economics
IntroductionThe majority of tuberculosis (TB) cases in Sweden occur among migrants from endemic countries through activation of latent tuberculosis infection (LTBI). Sweden has LTBI-screening policies for migrants that have not been previously evalua
Autor:
Salvador Amaral, Catarina Lopes, S. Vaz Nery, Kerri Viney, E. Baptista Marques, Andrew M. Siroka
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 23:1191-1197
SETTING: Seventeen health care facilities that report to the national tuberculosis (TB) programme in Timor-Leste. Participants were TB patients.OBJECTIVE: To determine the proportion of TB patients who experienced catastrophic costs due to their TB d
Autor:
Roberta Maria Antonello, Mario C. Raviglione, Marco Confalonieri, Andrew M. Siroka, S. Di Bella, R Tominz, Roberto Luzzati, Massimo Maschio, Matteo Zignol, G. B. Migliori, Daniela Maria Cirillo
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 23:1024-1028
SETTING: Early diagnosis of latent tuberculous infection (LTBI) should be pursued in healthcare workers (HCWs). While HCWs in hospitals are screened for LTBI, HCWs in outpatient settings are usually not. In 2017, in Italy, a tuberculosis (TB) infecte
Autor:
Katherine Floyd, Nicolas A Menzies, Gabriella B. Gomez, Richard G. White, Philippe Glaziou, Rein M G J Houben, Christopher Finn McQuaid, Andrew M. Siroka
Publikováno v:
The International Journal of Tuberculosis and Lung Disease
Mathematical modelling is commonly used to evaluate policy options for tuberculosis (TB) control in high-burden countries. Although major policy and funding decisions are made based on these analyses, there is concern about the variability of results
Autor:
Portia Boakye Okyere, Alexander Kwarteng, Frank Bonsu, Ellis Owusu-Dabo, Anna S. Dean, Wayne van Gemert, Rexford Mawunyo Dumevi, Yaw Adusi-Poku, Louis Adu-Amoah, Sampson Twumasi-Ankrah, Nicholas Addofoh, Francisca Dzata, Michael Owusu, Katharina Kranzer, Rejoice Agyeiwaa Arthur, Andrew M. Siroka, Augustina Sylverken
Publikováno v:
PLoS ONE, Vol 16, Iss 6 (2021)
PLoS ONE, Vol 16, Iss 6, p e0252819 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0252819 (2021)
PLoS ONE
Resistance to Tuberculosis drugs has become a major threat to the control of tuberculosis (TB) globally. We conducted the first nation-wide drug resistance survey to investigate the level and pattern of resistance to first-line TB drugs among newly a
Autor:
Craig van Rensburg, Caroline Govathson, Friedrich Rieß, Abdou K. Sillah, Farzana Sathar, Andrew M. Siroka, Sydney Rosen, Ilesh V. Jani, Nyanda E. Ntinginya, Denise Evans, Knut Lönnroth, Ian Sanne, Andrea Rachow, Olena Ivanova
Publikováno v:
Global Health Action, Vol 14, Iss 1 (2021)
Global Health Action
article-version (VoR) Version of Record
Global Health Action
article-version (VoR) Version of Record
The WHO developed a generic ‘TB patient cost survey’ tool and a standardized approach to assess the direct and indirect costs of TB incurred by patients and their households, estimate the proportion of patients experiencing catastrophic costs, an
Autor:
Andrew M. Siroka, I Garcia Baena, Nguyen Viet Nhung, N. B. Hoa, L T Ngoc Anh, Nguyen Thu Anh, Knut Lönnroth
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 22:983-990
Introduction Progress towards ending tuberculosis (TB) in Viet Nam includes monitoring the costs borne by patients through periodic facility-based surveys. Objective To document the magnitude of costs incurred by TB-affected households and establish
Autor:
Diana Weil, Delia Boccia, Philippe Glaziou, Andrew M. Siroka, Daniel J Carter, Mario C. Raviglione, Knut Lönnroth, Katherine Floyd, Rein M G J Houben
Publikováno v:
The Lancet Global Health, Vol 6, Iss 5, Pp e514-e522 (2018)
The Lancet. Global Health
The Lancet Global Health
The Lancet. Global Health
The Lancet Global Health
Summary Background The End TB Strategy and the Sustainable Development Goals (SDGs) are intimately linked by their common targets and approaches. SDG 1 aims to end extreme poverty and expand social protection coverage by 2030. Achievement of SDG 1 is
Autor:
Christopher J L Murray, Sawyer W Crosby, Joseph L Dieleman, Ines Garcia Baena, Angela E Micah, Andrew M. Siroka, Maitreyi Sahu, Katherine Floyd, Anton C Harle, Golsum Tsakalos, Yanfang Su
Publikováno v:
The Lancet. Infectious diseases. 20(8)
Summary Background Estimates of government spending and development assistance for tuberculosis exist, but less is known about out-of-pocket and prepaid private spending. We aimed to provide comprehensive estimates of total spending on tuberculosis i
Autor:
Kiran Rade, Piotr Hippner, Christopher C. Whalen, Philip A. Eckhoff, Delia Boccia, Nimalan Arinaminpathy, James M. Trauer, Daniel P. Chin, Ines Garcia Baena, Yoko V. Laurence, Jeffrey W. Eaton, Grace H. Huynh, Nicolas A Menzies, Emma S. McBryde, Susmita Chatterjee, Vineet K. Chadha, Suvanand Sahu, David W. Dowdy, Michael E. Kimerling, Colleen Daniels, Nicola L. Foster, Sun Qiang, Gavin J. Churchyard, Hsien-Ho Lin, Joshua A. Salomon, Richard G. White, Surabhi Pandey, Eran Bendavid, Bradley G. Wagner, Chieh Yin Wu, Mehran Hosseini, Sandip Mandal, Sze-chuan Suen, Alison D. Grant, Andrew M. Siroka, Puneet Dewan, Stéphane Verguet, Andreas Handel, Andrew S. Azman, Lixia Wang, Gabriela B. Gomez, Fiammetta Bozzani, Justin T Denholm, Lucica Ditiu, David Mametja, Anna Vassall, Marek Lalli, Jeremy D. Goldhaber-Fiebert, Tom Sumner, Yogan Pillay, Stewart T. Chang, Carel Pretorius, Sedona Sweeney, Rein M G J Houben, Salome Charalambous, Ted Cohen
Publikováno v:
e826
e816
The Lancet Global Health, Vol 4, Iss 11, Pp e816-e826 (2016)
lancet global health, 4(11), e816-e826. Elsevier BV
e816
The Lancet Global Health, Vol 4, Iss 11, Pp e816-e826 (2016)
lancet global health, 4(11), e816-e826. Elsevier BV
Summary Background The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by 50% and mortality by 75% by 2025. We aimed to assess resource requirements and cost-effectiveness of strategies to achieve these targets in Chi